1 trial to start immediately that is for certain, Optina, 1 pivotal trial that has already been provided guidance by the FDA for Ampion is likely within a few weeks of beginning and Zertane is the only possible question mark.
Unlike 99% of other clinical trial that are very high risk, all three of these trials are exceptional low risk for the many reasons we all know.
The company has enough cash to get through the trials.....
There could be a surprise announcement about Zertane that could send shares soaring in seconds not leaving the shorts an opportunity to get out cheap.
There could be many surprise announcement about any of their drugs like NCE001 or about the revolutionary OR device.
There could be a surprise announcement of an unexpected nature that could send shares soaring.
and yet today shares are selling at almost an all time low of under $4.00 per share.
It looks like all the weak shareholder have gotten out and there is little selling left.
We know there are buyers on the sidelines waiting for the right time and that appears to be now.
At any rate, buy low and sell high . . . Ampio is low and is positioned to go very high.
God bless the shorts for creating more liquidity and volatility and for helping the current buyers get positioned.